Statements Data availability statement The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author
In clinical trials of Wegovy (FDA-approved semaglutide), participants achieved an average weight loss of approximately 15% over 68 weeks, with some participants achieving up to 20% with continued treatment and adherence, when combined with diet and exercise
Vitamin B12 Supplements Dietary supplements, on the other hand, are concentrated products (tablets, capsules, gummies, etc) that are designed to fill dietary gaps
Monitoring Treatment Response in Pernicious Anemia Its very important to keep an eye on patients with pernicious anemia to make sure vitamin B12 therapy is working
Wegovy has been clinically studied for weight management
Payer requests a record